We are offering Bortemib - Bortezomib 2 mg Injection that is intended for multiple myeloma and mantle-cell lymphoma. The medicine belongs to the class of drugs called proteasome inhibitors. It works basically by inhibiting the production of proteins which have an important role in the growth and multiplication of cancer cells. It works by blocking the action of proteasome, and thus reducing the growth of cancerous (actively growing) cells. Recommended as a targeted therapy, this medicine is also given after other cancer medications have been tried in some cases.